Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entresto in post-acute myocardial infarction (RSVP-AMI)
NCT03893435Completed
- Sponsor
- Young Investigator Group of Cardiovascular Research
- Start
- Dec 2018
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of sacubitril + valsartan in acute myocardial infarction (AMI) (2 arms), sponsored by Young Investigator Group of Cardiovascular Research. Primary endpoints: Major Adverse Cerebrovascular and Cardiovascular Events at 1 week, Major Adverse Cerebrovascular and Cardiovascular Events at 24 weeks and 1 more. Started Dec 2018; status: completed.
02
Drugs
sacubitril + valsartan
03
Conditions
acute myocardial infarction (AMI)
Beyond the preview
Go deeper on NCT03893435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03893435.